Metabolic Changes Associated With Weight Gain After Treatment of Achalasia
1 other identifier
observational
30
1 country
2
Brief Summary
This goal of the study is to assess the effect of weight gain in patients with achalasia after they are treated. The main question to be answered is if weight gain after achalasia treatment is associated with worsening metabolic status. Patients will be compared between their baseline status at the time of treatment and 1 year after treatment. Participants will have metabolic tests performed at these 2 times including blood tests.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2026
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 31, 2025
CompletedFirst Posted
Study publicly available on registry
January 12, 2026
CompletedStudy Start
First participant enrolled
January 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2029
January 13, 2026
January 1, 2026
2 years
December 31, 2025
January 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Increase in Hepatic steatosis
The degree of hepatic steatosis assessed on FibroScan at baseline compared to 1 year later
1 year
Secondary Outcomes (10)
fasting glucose
1 year
Hgb A1c
1 year
Cholesterol
1 year
Triglycerides
1 year
Weight
1 year
- +5 more secondary outcomes
Study Arms (1)
Achalasia patients
Patients with achalasia who undergoing treatment with either per oral endoscopic myotomy (POEM) or laparoscopic Heller myotomy (LHM). Each participant's metabolic status will be evaluated at the time of treatment and one year later.
Eligibility Criteria
Patients diagnosed with achalasia and undergoing therapy with either POEM or LHM
You may qualify if:
- Proven achalasia
- Undergoing LHM or POEM for treatment
You may not qualify if:
- Under age 18
- Does no consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Assaf-Harofeh Medical Centerlead
- Hadassah Medical Organizationcollaborator
Study Sites (2)
Hadassah Medical Center
Jerusalem, Israel
Shamir Medical Center
Ẕerifin, Israel
Related Publications (2)
Patel DA, Vaezi MF. Achalasia and Nutrition: Is it Simple Physics or Biology. Pract Gastro. 2016 Nov;40(11):42-48.
BACKGROUNDPandolfino JE, Gawron AJ. Achalasia: a systematic review. JAMA. 2015 May 12;313(18):1841-52. doi: 10.1001/jama.2015.2996.
PMID: 25965233BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Gastroenterologist
Study Record Dates
First Submitted
December 31, 2025
First Posted
January 12, 2026
Study Start
January 15, 2026
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
January 1, 2029
Last Updated
January 13, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
The confidential information will only be used for this study.